van der Starre P J, van Heekeren K, Reneman R S
Department of Anesthesiology, Medical Center De Klokkenberg, Breda, The Netherlands.
J Hypertens Suppl. 1987 Dec;5(5):S205-8.
Ketanserin, a selective S2-serotonergic receptor antagonist with alpha 1-adrenergic receptor-blocking properties, as well as nifedipine, a classic calcium channel blocker, is used as an antihypertensive agent during and following cardiac surgery. In a double-blind prospective study, using hypothermic cardiopulmonary bypass as a study model, ketanserin (10 mg i.v.) and nifedipine (2 mg i.v.) were evaluated with respect to their effects on the peripheral circulation. The results showed that ketanserin and nifedipine dilate the arterial side of the vasculature, but that ketanserin, unlike nifedipine, also dilates the venous capacitance vessels; nifedipine even caused a short-lasting venous vasoconstriction. Since venous tone is increased during and following cardiopulmonary bypass, antihypertensive treatment with ketanserin might be advantageous under these circumstances.
酮色林是一种具有α1 -肾上腺素能受体阻断特性的选择性5-羟色胺2型(5-HT2)受体拮抗剂,以及硝苯地平,一种经典的钙通道阻滞剂,在心脏手术期间及术后用作抗高血压药物。在一项双盲前瞻性研究中,以低温体外循环作为研究模型,对酮色林(静脉注射10毫克)和硝苯地平(静脉注射2毫克)对外周循环的影响进行了评估。结果表明,酮色林和硝苯地平均可扩张血管系统的动脉侧,但与硝苯地平不同的是,酮色林还可扩张静脉容量血管;硝苯地平甚至引起短暂的静脉血管收缩。由于在体外循环期间及之后静脉张力会增加,因此在这些情况下使用酮色林进行抗高血压治疗可能具有优势。